Literature DB >> 20430302

Comorbidities in psoriasis patients.

Noori Kim1, Breck Thrash, Alan Menter.   

Abstract

Psoriasis is a chronic inflammatory disorder that affects approximately 2% of the general population. Numerous studies have evaluated the increased prevalence of comorbid diseases and risk factors in psoriatic patients, including obesity, metabolic syndrome, cardiovascular disease, psoriatic arthritis, autoimmune disease, psychiatric illness, liver disease, smoking, malignancy, chronic obstructive pulmonary disease, sleep apnea, and alcohol abuse. Insight into the overlapping pathogenesis of these comorbidities of psoriasis highlights the importance of immune-mediated mechanisms in these disease states. Psoriasis, with its comorbidities, must be approached in a multidisciplinary manner to effectively and comprehensively understand, manage, and treat those with this complex disorder.

Entities:  

Mesh:

Year:  2010        PMID: 20430302     DOI: 10.1016/j.sder.2010.01.002

Source DB:  PubMed          Journal:  Semin Cutan Med Surg        ISSN: 1085-5629


  35 in total

Review 1.  Emerging Associations Between Neutrophils, Atherosclerosis, and Psoriasis.

Authors:  G E Sanda; A D Belur; H L Teague; Nehal N Mehta
Journal:  Curr Atheroscler Rep       Date:  2017-10-30       Impact factor: 5.113

2.  Psoriasis.

Authors:  Anatoli Freiman; Benjamin Barankin
Journal:  CMAJ       Date:  2012-09-04       Impact factor: 8.262

3.  Unmasking the Janus face of the association between psoriasis, metabolic syndrome and obstructive sleep apnea.

Authors:  Maria Dalamaga; Evangelia Papadavid; Katerina Vlami
Journal:  Sleep Breath       Date:  2012-07-21       Impact factor: 2.816

4.  Psoriasis is associated with risk of obstructive sleep apnea independently from metabolic parameters and other comorbidities: a large hospital-based case-control study.

Authors:  Evangelia Papadavid; Maria Dalamaga; Katerina Vlami; Dimitra Koumaki; Sotirios Gyftopoulos; Gerasimos Socrates Christodoulatos; Spyridon Papiris; Dimitrios Rigopoulos
Journal:  Sleep Breath       Date:  2017-05-08       Impact factor: 2.816

5.  Kaempferol attenuates imiquimod-induced psoriatic skin inflammation in a mouse model.

Authors:  C Liu; H Liu; C Lu; J Deng; Y Yan; H Chen; Y Wang; C-L Liang; J Wei; L Han; Z Dai
Journal:  Clin Exp Immunol       Date:  2019-08-26       Impact factor: 4.330

Review 6.  Psoriasis as a human model of disease to study inflammatory atherogenesis.

Authors:  Charlotte L Harrington; Amit K Dey; Raza Yunus; Aditya A Joshi; Nehal N Mehta
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-03-03       Impact factor: 4.733

7.  Lower frequency of obstructive sleep apnea in spondyloarthritis patients taking TNF-inhibitors.

Authors:  Jessica A Walsh; Kristina Callis Duffin; Julia Crim; Daniel O Clegg
Journal:  J Clin Sleep Med       Date:  2012-12-15       Impact factor: 4.062

8.  Prevalence of cardiovascular risk factors in patients with psoriatic arthritis.

Authors:  Majed Khraishi; Rana Aslanov; Emmanouil Rampakakis; Clare Pollock; John S Sampalis
Journal:  Clin Rheumatol       Date:  2014-07-18       Impact factor: 2.980

Review 9.  IL-17 in psoriasis: implications for therapy and cardiovascular co-morbidities.

Authors:  Jackelyn B Golden; Thomas S McCormick; Nicole L Ward
Journal:  Cytokine       Date:  2013-04-04       Impact factor: 3.861

Review 10.  Chronic inflammation, cardiometabolic diseases and effects of treatment: Psoriasis as a human model.

Authors:  Milena Aksentijevich; Sundus S Lateef; Paula Anzenberg; Amit K Dey; Nehal N Mehta
Journal:  Trends Cardiovasc Med       Date:  2019-11-20       Impact factor: 6.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.